Efficacy and Safety of SGLT2 Inhibitors in Type 1 Diabetes After the Introduction of an Off-Label Use Protocol for Clinical Practice

Diabetes Technology&Therapeutics, Ahead of Print.

Source: Diabetes Technology and Therapeutics - October 22, 2019 Category: Endocrinology Authors: Ane Bayona Cebada L ía Nattero-Chávez Sara Alonso D íaz H éctor F. Escobar-Morreale Manuel Luque-Ram írez Source Type: research